Activities of Daily Living (ADL) Virtual Reality (VR) for Acquired Brain Injury (ABI) Upper-Limb Rehabilitation
Launched by INDIANA UNIVERSITY · Jun 10, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of therapy using virtual reality (VR) to help people recover movement and function in their arms after a brain injury, such as a stroke. The VR program focuses on activities of daily living, like tasks you do every day, to make rehabilitation more engaging and effective. Researchers want to see how well this VR system works when added to regular treatment plans for people with upper-limb weakness caused by brain injury.
People who might be eligible for this study are adults aged 65 to 74 who have had an acquired brain injury affecting their arm movement, are able to follow instructions, and are at least two months into their recovery after a stroke. To join, participants need to have a certain level of arm function (measured by a specific test) and no health issues like seizures or severe vision problems that could make VR unsafe or difficult to use. If selected, participants will use the VR system as part of their therapy, helping them practice everyday movements in a virtual setting designed to support their recovery. This study is not yet recruiting participants, but it aims to offer a promising new way to improve arm rehabilitation after brain injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • acquired brain injury with upper extremity impairment
- • Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score of 20 points or more
- • able to follow commands and instructions
- • least 2 months post-stroke, in the subacute or chronic recovery phase
- Exclusion Criteria:
- • - contraindications that increase susceptibility to VR-related adverse events and/or prevent completion of training tasks, such as seizures, epilepsy, visual acuity deficits (besides glasses), vertigo, nystagmus, motion sensitivity, or other non-ABI conditions that impede upper limb movement
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Hee-Tae Jung, Ph.D.
Principal Investigator
Indiana University, Luddy School of Informatics, Computing, and Engineering
Peter Altenburger, Ph.D., PT
Principal Investigator
Indiana University, School of Health & Human Sciences; Indiana University Health, Center for Advanced Neurorehabilitation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported